Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Interleukin-2 for Resected Renal Cancer
NCT00003604Phase 2Unknown
- Sponsor
- Cancer Biotherapy Research Group
- Start
- Oct 1997
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in renal cell carcinoma (RCC), sponsored by Cancer Biotherapy Research Group. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003604.